Keywords: بواسیزوماب; bevacizumab; antibody; voltammetry; glassy carbon electrode; denaturing agents;
مقالات ISI بواسیزوماب (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بواسیزوماب; Bevacizumab; Colorectal cancer; Efatutazone; EGFR inhibitors; Erlotinib; Maintenance; MGN1703; Treatment duration;
Keywords: بواسیزوماب; High grade glioma; Relapse; Stereotactic radiation; Bevacizumab; Pattern of relapseGliome de haut grade; Rechute; Irradiation en conditions stéréotaxiques; Bévacizumab; Site de rechute
Keywords: بواسیزوماب; Bevacizumab; chemotherapy; colorectal cancer; progression-free survival;
Keywords: بواسیزوماب; Lung adenocarcinomas; Bevacizumab; Nonplatinum chemotherapy; Pemetrexed; Paclitaxel;
Keywords: بواسیزوماب; Recurrent; Glioblastoma; Re-irradiation; Bevacizumab; Chemotherapy; NovoTTF;
Keywords: بواسیزوماب; subretinal hemorrhage; neovascular age-related macular degeneration; anti-vascular endothelial growth factor; bevacizumab; ranibizumab; tissue plasminogen activator; pneumatic displacement; vitrectomy; gas; macular translocation
Keywords: بواسیزوماب; Hereditary hemorrhagic telangiectasia (HHT); Osler-Weber-Rendu; Epistaxis; Septodermoplasty; Laser photocoagulation; Young's procedure; Bevacizumab;
Keywords: بواسیزوماب; Liver metastasis; Colorectal cancer; Liver resection; mFOLFOX6; Bevacizumab; Conversion; Neoadjuvant chemotherapy;
Keywords: بواسیزوماب; Ovarian cancer; Surgical debulking; Chemotherapy; BRCA1; BRCA2; Bevacizumab; PARP inhibitors; Immunotherapy;
Keywords: بواسیزوماب; aflibercept; bevacizumab; diabetes; diabetic macular edema; diabetic retinopathy; intravitreal anti-VEGF; laser photocoagulation; ranibizumab; retina; vascular endothelial growth factor; VEGF;
Keywords: بواسیزوماب; mAb; monoclonal antibody; BPD; benzoporphyrin derivative; PDT; photodynamic therapy; nanoPAL; nanophotoactivatable liposomes; PDAC; pancreatic ductal adenocarcinoma; VEGF; vascular endothelial growth factor; MAPK; mitogen activated protein kinases; HIF; h
Keywords: بواسیزوماب; Glioblastoma; MGMT; Temozolomide; Nitrosourea; Bevacizumab; Immunotherapy;
Keywords: بواسیزوماب; Glioma; Bevacizumab; Treatment protocol; Treatment quality; Bibliometrics
Keywords: بواسیزوماب; aflibercept; Avastin™; bevacizumab; diabetic macular edema; diabetic retinopathy; glycated hemoglobin (A1C); insulin therapy; metabolic parameters; ranibizumab; VEGF-inhibitorsaflibercept; AvastinMC; bévacizumab; œdème maculaire diabétique; hémoglobine gl
Keywords: بواسیزوماب; Diabetic macular edema; Bevacizumab; Laser; Subthreshold laser; Triamcinolone;
Keywords: بواسیزوماب; Renal insufficiency; Bevacizumab; Pemetrexed; Non-small cell lung cancer;
Keywords: بواسیزوماب; Bevacizumab; Cetuximab; Colorectal liver metastases; Histological response; Pattern of tumor destruction; Survival;
Keywords: بواسیزوماب; Head and neck cancer; Angiogenesis; Vascular endothelial growth factor; Vascular endothelial growth factor receptor; Targeted therapy; Tyrosine kinase inhibitors; Monoclonal antibodies; Bevacizumab;
Keywords: بواسیزوماب; Bevacizumab; Glioblastoma; Neurosurgery; Prognostic score; Recurrence; TemozolomideCCNU, Lomustine; GTR, Gross total resection; HR, Hazard ratio; KPS, Karnofsky performance status; MRI, Magnetic resonance imaging; NIH, National Institutes of Health; OR, O
Keywords: بواسیزوماب; Colorectal; Elderly; Bevacizumab; Chemotherapy; Surgery; Outcomes
Keywords: بواسیزوماب; Bevacizumab; Lapatinib; Sunitinib; Sorafenib; Rofecoxib; Celecoxib; Venlafaxine; Prednisone Licorice acid; cyclosporin A; Medications; Drug-induced hypertension; Blood pressure; chemicals; Tyrosine kinase inhibitors;
Keywords: بواسیزوماب; Chemotherapy; Liver regeneration; Bevacizumab
Keywords: بواسیزوماب; Bevacizumab; Cetuximab; Chemotherapy; Colorectal cancer; Panitumumab;
Keywords: بواسیزوماب; angiogenesis; bevacizumab; recurrent cervical cancer; therapeutic rationale; anti-angiogenesis therapy;
Keywords: بواسیزوماب; Nanotechnology; Nanoparticles; Retina; Vitreous; Sustained release; AMDCyclosporine A; Difluprednate; Aflibercept; Bevacizumab; Pegaptanib; Ranibizumab
Keywords: بواسیزوماب; angiogenesis; glaucoma; glaucoma filtration surgery; neovascular glaucoma; anti-VEGF therapy; bevacizumab; ranibizumab; anti-metabolites
Keywords: بواسیزوماب; Angiogenesis; Advanced gastric cancer; Bevacizumab; Ramucirumab
Keywords: بواسیزوماب; adverse sequelae; alopecia; antiangiogenic agents; anticancer; BCR-ABL; bevacizumab; cancer treatment; canertinib; cetuximab; chemotherapy; cutaneous adverse effects; dasatinib; dermatologic toxicities; disturbed wound healing; drug eruption; drug rash; d
Keywords: بواسیزوماب; Angiogenesis; Bevacizumab; Chemo-switching; Cyclophosphamide; Immunity; Maintenance; Metronomic chemotherapy; Toxicity
Keywords: بواسیزوماب; Epithelial ovarian cancer; Cervical cancer; Endometrial cancer; Bevacizumab; Molecular signatures; Pazopanib; Nintedanib; Trebanabib
Keywords: بواسیزوماب; anti-VEGF; bevacizumab; Histoplasma capsulatum; histoplasmosis; ocular histoplasmosis syndrome; photocoagulation; photodynamic therapy; presumed ocular histoplasmosis syndrome; ranibizumab; submacular surgery;
Keywords: بواسیزوماب; bevacizumab; branch retinal vein occlusion; central retinal vein occlusion; dexamethasone implant; macular edema
Keywords: بواسیزوماب; Drusas cuticulares; Bevacizumab; Desprendimiento viteliforme adquirido; Tomografía óptica de coherencia; AutofluorescenciaCuticular drusen; Bevacizumab; Acquired vitelliform detachment; Optical coherence tomography; Autofluorescence
Keywords: بواسیزوماب; age-related macular degeneration; antivascular endothelial growth factor; bevacizumab; glaucoma; intravitreal injections; ocular hypertension; ranibizumab
Keywords: بواسیزوماب; bevacizumab; optical coherence tomography; punctate inner choroidopathy
Keywords: بواسیزوماب; Arteriovenous malformation; VEGF; Bevacizumab; Obliteration; Radiosurgery
Keywords: بواسیزوماب; Antiangiogenic agents; Metastatic renal cells cancer; Complete response; Sunitinib; Sorafenib; Pazopanib; Bevacizumab; Cytokines; Interferon;
Keywords: بواسیزوماب; Radiation; Bevacizumab; Gynecologic malignancies
Keywords: بواسیزوماب; Recurrent epithelial ovarian cancer; Bevacizumab; Nomogram;
Keywords: بواسیزوماب; Ovarian cancer; Vascular endothelial growth factor receptor; Angiogenesis; Disseminated tumor cells; Bevacizumab
Keywords: بواسیزوماب; Chorioretinal neovascularization; Age macular degeneration; Bevacizumab; Flare; Néovascularisation choriorétinienne; Dégénérescence maculaire liée à l'âge; Bevacizumab; Flare;
Keywords: بواسیزوماب; Ovarian cancer; Bevacizumab; Cost-effectiveness; Subgroup; Platinum-resistant; Platinum sensitive;
Keywords: بواسیزوماب; Neovascularización; Bevacizumab; Ranibizumab; Córnea; Antifactor de crecimiento vascular endotelialNeovascularization; Bevacizumab; Ranibizumab; Cornea; Anti-vascular endothelial growth factor
Keywords: بواسیزوماب; Renal cell carcinoma; Sorafenib; Pazopanib; Everolimus; Sunitinib; Bevacizumab; Axitinib; Antiangiogenic therapy; Treatment algorithm;
Keywords: بواسیزوماب; Sinusoidal obstruction syndrome; Colorectal liver metastases; Bevacizumab; Oxaliplatin; Splenic volumeCRLM, colorectal liver metastases; OX, oxaliplatin; FU, fluorouracil; LV, leucovorin; SOS, sinusoidal obstruction syndrome; Bmab, bevacizumab; VEGF, vasc
Keywords: بواسیزوماب; Angiosarcoma; VEGF; VEGFR; Caprelsa; Bevacizumab; Citotoxicity
Keywords: بواسیزوماب; Biological agents (BA); Metastatic triple-negative breast cancer (mTNBC); Bevacizumab
Keywords: بواسیزوماب; Angiogenesis; Bevacizumab; Regorafenib; VEGF; Ziv-aflibercept;
Keywords: بواسیزوماب; SEC; Light-scattering; Capability indices; Control chart; Bevacizumab; Stability